how were glp 1 agonists discovered GLP-1 medications are not approved by the Food and Drug Administration to treat polyendocrine metabolic ovarian syndrome (PMOS), the condition renamed from polycystic ovary syndrome in 2026. Because the use is off-label Comparing Ozempic, Wegovy and Other

Our strategies can support brain, hormonal and gut health to promote an improved quality of life

Regulatory bodies are increasingly aware of consumer demand for antioxidants and are facilitating health claims, encouraging manufacturers to understand which claims resonate with their audience

The study found that tissue glycine levels in many individuals fall below the Michaelis constant for the enzyme glutathione synthase, meaning the enzyme cannot operate at full capacity

Kornblau SM, Konopleva M, Andreeff M

If you need personalized guidance, reach out to the SportsOne team for expert advice

Whether a cosmetic serum reproduces all of those effects depends on formulation and delivery